The fact that those with a BMI of 27kg/m 2 or higher according to the SELECT trial [27] could not be considered may also have had an impact
Twenty years of cardiovascular complications and risk factors in patients with type 2 diabetes: a nationwide Swedish cohort study
Important data GLP-1 RAs appear to be modestly effective and safe (no increase in severe hypoglycemia or DKA) SGLT-2i also effective and generally safe with increased risk of DKA (risk ratios = 2.19, 95% confidence interval 1.164.17 We desperately need more outcome data in T1DM population These patients deserve both GLP-1-based therapies and SGLT2i and we should generate enough data to find the way how to administer it safely and effectively To view or add a comment, sign in THE SUSPENDED BREATH: REDEFINING AIR IN BRONCHIAL ASTHMA Bronchial asthma is not just a wheeze or a nocturnal cough, but a silent battle for air, where the lungs tighten like an inflammatory vice, making every breath an act of will
EFFECTS ON ABILITY TO DRIVE*: Patients ability to concentrate and react may be impaired as a result of hypoglycaemia or hyperglycaemia or, for example, as a result of visual impairment
Support is primarily clinical, with guidance on side effects, titration, and hunger regulation, plus educational onboarding and responsive email or phone support when needed
Patients who have had mixed or unclear GLP-1 responses in the past, or who want biomarker context before starting treatment, may benefit from PlexusDx's genetic-pathway option